Given the prevalence of oncology and low efficacy rates, the need to develop more safe, effective, and targeted therapies for specific cancer indications has never been so high. It is critical to discover and develop the right drugs for the right patients at the right time, fulfilling the promise of precision medicine.
As such, we create insights to optimize how you progress more effective and precise cancer treatments to specific patients in need.
Accelerating the Development of More Effective & Precise Oncology Therapies to Targeted Patient Populations
Developing safer and more effective targeted therapeutics for specific cancer indications remains a huge unmet medical need. Therefore, gaining access to the latest scientific advancements, novel targets and benchmarking clinical progress to demonstrate safety and efficacy remains critical.
For over a decade we’ve worked closely with biopharma to provide valuable insights and meaningful connections to understand novel therapeutic modalities, enhance clinical trial design, and minimize on/off target toxicities to improve safety and predict positive patient responders.
From industry-defining conferences, clinical trials database to tailored market research and expert networks, we provide meaningful insights to accelerate the development of your precision oncology pipeline to targeted patient populations.
Featured Precision Oncology Products
11th Tumor Models Boston
13th World Clinical Biomarkers & CDx Boston
mRNA Cancer Vaccine Summit
Precision Oncology Products by Type
Make Faster, Better Drug Development Decisions
Premium Insight and Meaningful Connections for Biopharma
7th LBx for Precision Oncology Summit
Expert-driven, Life Science Market Intelligence Solutions
Get in touch
We speak to hundreds of biopharmaceutical experts from industry and academia every day. We would love for you to be one of them. Contact us to discover how our events can accelerate your drug development.
Standard Form - Precision Oncology
"*" indicates required fields